Clinical trial
Efficacy Study of Nicorandil on Neointima After Coronary Drug-eluting Stent Implantation in Patients With Diabetic Mellitus
NCT02328521 is registered in ClinicalTrials.gov with Zhang Ying Qian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Study of Nicorandil on Neointima After Coronary Drug-eluting Stent Implantation in Patients With Diabetic Mellitus
- Lead sponsor
- Zhang Ying Qian
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2014
- Completion date
- July 31, 2016
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.